e-mailprint

Terumo to Sponsor Presentations on Key Issues in Cardiac and Vascular Surgery at Association of Thoracic Surgery Annual Meeting

Ann Arbor, MICHIGAN — April 9, 2010 — Terumo announced it has finalized its agenda of sponsored presentations at the Annual Meeting of the Association of Thoracic Surgery (AATS) in Toronto, Canada, May 2-4. The presentations cover emerging topics in aortic root surgery, currently of intense interest in the cardiovascular community.

Terumo will be represented at the AATS by its three subsidiaries that develop, manufacture and market products for cardiac and vascular surgery: Terumo Cardiovascular Systems (Terumo CVS) produces products for cardiopulmonary bypass, endoscopic vessel harvesting and intraoperative monitoring; Terumo Heart, Inc. produces the DuraHeart™ Left Ventricular Assist System, currently in clinical trials in the U.S.; Vascutek Ltd. is a leading manufacturer of vascular grafts. All product lines will be represented at the Terumo exhibit.

"The AATS Annual Meeting is an important venue for Terumo,” said Mark Sutter, President and CEO of Terumo Cardiovascular Systems. "It is one of the best opportunities for Terumo to demonstrate the strength of its broader cardiac and vascular portfolio. We share with AATS the goal of bringing together industry and clinicians from all over the world to exchange information relevant to advancing cardiovascular surgery.”

Terumo estimates that its products are used in more than 1000 cardiac and vascular surgeries every day, including coronary artery bypass grafting, valve replacements, heart transplants, aortic aneurysm repair, and surgeries for peripheral artery disease.

 

About Terumo's Cardiac and Vascular Surgery Subsidiaries

Terumo Cardiovascular Systems Corporation is a global manufacturer and marketer of medical devices for cardiac and vascular surgery. The company is headquartered in Ann Arbor, Michigan with manufacturing operations in Ann Arbor; Elkton, Maryland; and Ashland, Massachusetts. For more information, visit www.terumo-cvs.com.

Terumo Heart, Inc. has headquarters and manufacturing facilities in Ann Arbor, Michigan. The company's focus is the innovation and introduction of products to improve the quality of healthcare for heart failure patients. The DuraHeart system is limited to investigational use only in the United States, and is CE marked in Europe. For more information, visit www.terumoheart.com.

Vascutek Ltd., based outside of Glasgow, Scotland, is one of the world's leading designers, manufacturers and marketers of vascular products for the treatment of cardiovascular disease, including a wide range of sealed and unsealed knitted and woven polyester and ePTFE vascular prosthetic grafts. For more information, visit www.vascutek.com.

Terumo Corporation is a premier global medical device company with annual sales of more than three billion dollars for the year ending March 31, 2009. Founded in 1921, the company develops, manufactures and distributes world-class medical devices for use in cardiothoracic surgery, interventional procedures, transfusion medicine, and needle and syringe products.

Media contact: Barbara Schmid Director, Corporate Communications Terumo Cardiovascular Systems (734) 741-6362 (734) 657-6860 (cell)